Recombinant multi-species ASL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ASL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2510006M18Rik,ASAL,ASL,Argininosuccinate lyase,Arginosuccinase,Asl
Go
to ASL products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8854-Ag-1/ GM-Tg-hg-IP8854-Ag-2 | Human ASL protein | Human |
| GM-Tg-rg-IP8854-Ag-1/ GM-Tg-rg-IP8854-Ag-2 | Rat ASL protein | Rat |
| GM-Tg-mg-IP8854-Ag-1/ GM-Tg-mg-IP8854-Ag-2 | Mouse ASL protein | Mouse |
| GM-Tg-cynog-IP8854-Ag-1/ GM-Tg-cynog-IP8854-Ag-2 | Cynomolgus/Rhesus macaque ASL protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8854-Ag-1/ GM-Tg-felg-IP8854-Ag-2 | Feline ASL protein | Feline |
| GM-Tg-cang-IP8854-Ag-1/ GM-Tg-cang-IP8854-Ag-2 | Canine ASL protein | Canine |
| GM-Tg-bovg-IP8854-Ag-1/ GM-Tg-bovg-IP8854-Ag-2 | Bovine ASL protein | Bovine |
| GM-Tg-equg-IP8854-Ag-1/ GM-Tg-equg-IP8854-Ag-2 | Equine ASL protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8854-Ag-1/ GM-Tg-hg-IP8854-Ag-2;
GM-Tg-rg-IP8854-Ag-1/ GM-Tg-rg-IP8854-Ag-2;
GM-Tg-mg-IP8854-Ag-1/ GM-Tg-mg-IP8854-Ag-2; GM-Tg-cynog-IP8854-Ag-1/ GM-Tg-cynog-IP8854-Ag-2; GM-Tg-felg-IP8854-Ag-1/ GM-Tg-felg-IP8854-Ag-2; GM-Tg-cang-IP8854-Ag-1/ GM-Tg-cang-IP8854-Ag-2; GM-Tg-bovg-IP8854-Ag-1/ GM-Tg-bovg-IP8854-Ag-2; GM-Tg-equg-IP8854-Ag-1/ GM-Tg-equg-IP8854-Ag-2 |
| Products Name | ASL protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ASL |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ASL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.